India Biosimilar Cetuximab Go-Ahead: Merck KGaA Wants Data In Public Domain

 
• By Anju Ghangurde
  
Merck seeks biosimilar cetuximab data be placed in the public domain • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia